Trial NCT03036930

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

This trial studies whether the nonavalent human papillomavirus vaccine given to adults prior
to kidney transplantation can help the body build and maintain an effective immune response
during the post-transplant period when they receive immunosuppressive drugs to prevent
transplant rejection. This study will help inform our scientific understanding about
vaccine-induced immune responses among immunosuppressed individuals.

Intervention

Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine

Condition

Kidney Transplantation

Investigators

Lisa Rahangdale, Garrett R. Roll, E. T. Overton, Michael Ison, Irene Kim

See list of participating sites